Elijahu Berkovich
Head of Emerging Science and Innovation
Clexio Biosciences
Dr. Elijahu Berkovich is a scientist with over 10 years of pharmaceutical industry experience. Elijahu brings the unique ability to identify and explore medical unmet needs, propose novel therapeutic solutions, develop concepts and test them in preclinical models and in human. His wide experience spans across R&D (from idea to commercial), Due Diligence of new projects and business opportunities (internal and external), Marketing and Medical/Scientific Affairs. Elijahu serves as the Head of Emerging Science and Innovation at Clexio Biosciences where he is responsible for ideation, scouting and pipeline creation. Prior to his role as Head of Emerging Science and Innovation at Clexio, Elijahu was a Senior Director at Teva Pharmaceuticals, holding various positions within Global R&D and Medical Affairs. Elijahu holds a bachelor degree in Biochemistry and Food Science (with highest distinction) from the Hebrew University of Jerusalem and a M.Sc. and Ph.D. (with distinction) in Molecular and Cellular Biology from the Weizmann Institute of Science. Elijahu completed his Post-doctoral fellowship in the Hematology/Oncology Department at St. Jude Children’s Hospital, Memphis, TN, where he focused his research on Oncology and DNA damage response and published peer-reviewed articles in top tier journals.